FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chemotherapy Effect
- Colon Cancer
- Resistance Training
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: This randomized controlled trial of resistance training intervention in colon cancer patients receiving chemotherapy consists of two arms: an in-person and telephone-based intervention to promote home-based resistance training, and a wait-list, control group.Masking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03291951
- Collaborators
- Dana-Farber Cancer Institute
- Penn State University
- Investigators
- Principal Investigator: Bette J Caan, DrPH Kaiser Permanente Principal Investigator: Kathryn H Schmitz, PhD, MPH Penn State Cancer Institute Principal Investigator: Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute